Clinical Trial: Denosumab and Male Infertility: a RCT

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Denosumab and Male Infertility: a Randomized Controlled Double-blinded Intervention Study

Brief Summary: To determine the significance of systemic RANKL inhibition for male reproduction, conducting a clinical controlled randomized double blinded intervention study on infertile men, to investigating whether Denosumab (Prolia) can increase semen quality and to investigate what subgroup of infertile men that might benefit from treatment.